Immunogenic Targets for Specific Immunotherapy in Multiple Myeloma

Multiple myeloma remains an incurable disease although the prognosis has been improved by novel therapeutics and agents recently. Relapse occurs in the majority of patients and becomes fatal finally. Immunotherapy might be a powerful intervention to maintain a long-lasting control of minimal residua...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lu, Götz, Marlies, Hofmann, Susanne, Greiner, Jochen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352660/
https://www.ncbi.nlm.nih.gov/pubmed/22611422
http://dx.doi.org/10.1155/2012/820394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352660/
https://www.ncbi.nlm.nih.gov/pubmed/22611422
http://dx.doi.org/10.1155/2012/820394

Ejemplares similares